CA2001502A1 - Cyclosporin ophthalmic compositions - Google Patents
Cyclosporin ophthalmic compositionsInfo
- Publication number
- CA2001502A1 CA2001502A1 CA002001502A CA2001502A CA2001502A1 CA 2001502 A1 CA2001502 A1 CA 2001502A1 CA 002001502 A CA002001502 A CA 002001502A CA 2001502 A CA2001502 A CA 2001502A CA 2001502 A1 CA2001502 A1 CA 2001502A1
- Authority
- CA
- Canada
- Prior art keywords
- eye
- composition
- composition according
- compositions
- ciclosporin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26286688A | 1988-10-26 | 1988-10-26 | |
US262,866 | 1988-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2001502A1 true CA2001502A1 (en) | 1990-04-26 |
Family
ID=22999400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002001502A Abandoned CA2001502A1 (en) | 1988-10-26 | 1989-10-25 | Cyclosporin ophthalmic compositions |
Country Status (24)
Country | Link |
---|---|
JP (1) | JPH02164830A (de) |
KR (1) | KR900005973A (de) |
AU (1) | AU626928B2 (de) |
BE (1) | BE1003578A4 (de) |
CA (1) | CA2001502A1 (de) |
CH (1) | CH679210A5 (de) |
DE (1) | DE3935517A1 (de) |
DK (1) | DK531289A (de) |
ES (1) | ES2020032A6 (de) |
FI (1) | FI895064A0 (de) |
FR (1) | FR2638089A1 (de) |
GB (1) | GB2224205B (de) |
GR (1) | GR1000611B (de) |
HU (1) | HU203046B (de) |
IL (1) | IL92120A (de) |
IT (1) | IT1237824B (de) |
LU (1) | LU87613A1 (de) |
MY (1) | MY106271A (de) |
NL (1) | NL8902657A (de) |
NO (1) | NO894266L (de) |
NZ (1) | NZ231131A (de) |
PT (1) | PT92120B (de) |
SE (1) | SE8903583L (de) |
ZA (1) | ZA898140B (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0148748B1 (ko) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
CA2002147A1 (en) * | 1988-11-07 | 1990-05-07 | Shuichi Morikawa | Production process for polyimide fibers |
US5540931A (en) * | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
US4996193A (en) * | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
FR2670629B1 (fr) * | 1990-12-17 | 1995-03-10 | Moving Magnet Tech | Actionneur electromagnetique monophase rotatif. |
US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
ZA927277B (en) * | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
JP3631490B2 (ja) | 1992-05-13 | 2005-03-23 | ノバルティス ファーマ株式会社 | シクロスポリン含有眼科用組成物 |
US5366739A (en) * | 1992-08-06 | 1994-11-22 | Deo Corporation | Method of ophthalmic drug delivery |
US5830508A (en) * | 1992-08-06 | 1998-11-03 | Deo Corporation | Composition for treating dry eye |
PT589843E (pt) | 1992-09-25 | 2002-04-29 | Novartis Ag | Composicoes farmaceuticas contendo ciclosporinas |
US5698533A (en) * | 1994-07-26 | 1997-12-16 | Kang; Meng-Che | Ophthalmic pharmaceutical composition |
DK0789580T3 (da) | 1994-11-03 | 2002-09-09 | Novartis Ag | Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling |
US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
EP0988046B1 (de) | 1997-01-30 | 2004-09-15 | Novartis AG | Ölfreie pharmazeutische zusammensetzung welche cyclosporin enthält |
US6254860B1 (en) * | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
US7557082B2 (en) | 2006-03-03 | 2009-07-07 | Allergan, Inc. | Treatment with cyclosporin A |
KR20100067684A (ko) * | 2007-11-05 | 2010-06-21 | 보오슈 앤드 롬 인코포레이팃드 | 약물 전달을 위한 비히클로서의 수불혼화성 물질 |
BRPI1011710B8 (pt) * | 2009-06-05 | 2021-05-25 | Allergan Inc | composição para ser usada como uma lágrima artificial |
CA2967413C (en) | 2014-11-25 | 2023-08-15 | Allergan, Inc. | Ophthalmic compositions containing omega-3 oils stabilized by antioxidants |
EP4201398A1 (de) * | 2021-12-24 | 2023-06-28 | Isoxa S.r.l. | Isocyclosporin a zur topischen behandlung von augenerkrankungen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649047A (en) * | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
US4839342A (en) * | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
-
1989
- 1989-10-24 FR FR8914023A patent/FR2638089A1/fr active Pending
- 1989-10-24 BE BE8901138A patent/BE1003578A4/fr not_active IP Right Cessation
- 1989-10-24 CH CH3835/89A patent/CH679210A5/de not_active IP Right Cessation
- 1989-10-25 GR GR890100690A patent/GR1000611B/el unknown
- 1989-10-25 IL IL9212089A patent/IL92120A/en not_active IP Right Cessation
- 1989-10-25 NZ NZ231131A patent/NZ231131A/en unknown
- 1989-10-25 DK DK531289A patent/DK531289A/da not_active Application Discontinuation
- 1989-10-25 FI FI895064A patent/FI895064A0/fi not_active Application Discontinuation
- 1989-10-25 CA CA002001502A patent/CA2001502A1/en not_active Abandoned
- 1989-10-25 HU HU895444A patent/HU203046B/hu not_active IP Right Cessation
- 1989-10-25 KR KR1019890015328A patent/KR900005973A/ko not_active Application Discontinuation
- 1989-10-25 DE DE3935517A patent/DE3935517A1/de not_active Withdrawn
- 1989-10-25 GB GB8924040A patent/GB2224205B/en not_active Expired - Lifetime
- 1989-10-25 AU AU43715/89A patent/AU626928B2/en not_active Ceased
- 1989-10-25 JP JP1276174A patent/JPH02164830A/ja active Pending
- 1989-10-26 IT IT04848589A patent/IT1237824B/it active IP Right Grant
- 1989-10-26 MY MYPI89001487A patent/MY106271A/en unknown
- 1989-10-26 LU LU87613A patent/LU87613A1/fr unknown
- 1989-10-26 PT PT92120A patent/PT92120B/pt not_active IP Right Cessation
- 1989-10-26 ZA ZA898140A patent/ZA898140B/xx unknown
- 1989-10-26 NO NO89894266A patent/NO894266L/no unknown
- 1989-10-26 SE SE8903583A patent/SE8903583L/ not_active Application Discontinuation
- 1989-10-26 NL NL8902657A patent/NL8902657A/nl not_active Application Discontinuation
- 1989-10-26 ES ES8903619A patent/ES2020032A6/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB2224205A (en) | 1990-05-02 |
GR890100690A (en) | 1990-11-29 |
LU87613A1 (fr) | 1991-05-07 |
AU626928B2 (en) | 1992-08-13 |
MY106271A (en) | 1995-04-29 |
DK531289A (da) | 1990-04-27 |
CH679210A5 (de) | 1992-01-15 |
PT92120B (pt) | 1995-06-30 |
DK531289D0 (da) | 1989-10-25 |
IT8948485A0 (it) | 1989-10-26 |
NO894266D0 (no) | 1989-10-26 |
AU4371589A (en) | 1990-05-03 |
HUT52394A (en) | 1990-07-28 |
HU895444D0 (en) | 1990-01-28 |
IL92120A0 (en) | 1990-07-12 |
SE8903583L (sv) | 1990-04-27 |
IT1237824B (it) | 1993-06-18 |
ES2020032A6 (es) | 1991-07-16 |
NO894266L (no) | 1990-04-27 |
GB2224205B (en) | 1992-04-15 |
SE8903583D0 (sv) | 1989-10-26 |
NZ231131A (en) | 1992-06-25 |
GR1000611B (el) | 1992-08-31 |
FR2638089A1 (fr) | 1990-04-27 |
DE3935517A1 (de) | 1990-05-03 |
KR900005973A (ko) | 1990-05-07 |
GB8924040D0 (en) | 1989-12-13 |
FI895064A0 (fi) | 1989-10-25 |
NL8902657A (nl) | 1990-05-16 |
JPH02164830A (ja) | 1990-06-25 |
PT92120A (pt) | 1990-04-30 |
ZA898140B (en) | 1991-06-26 |
HU203046B (en) | 1991-05-28 |
IL92120A (en) | 1994-02-27 |
BE1003578A4 (fr) | 1992-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU626928B2 (en) | Cyclosporin opthalmic compositions | |
US5951971A (en) | Ophthalmic compositions | |
Constad et al. | Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma | |
EP0089815B1 (de) | Flüssige Perfluorkohlenstoffe zur Augentherapie sowie diese enthaltende Zusammenstellungen | |
US5308624A (en) | Ophthalmic product | |
CZ423797A3 (cs) | Topické přípravky s imunosupresivy | |
Miki et al. | Intraocular cannula for continuous, chronic drug delivery: histopathologic observations and function | |
EP0380560A1 (de) | Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks. | |
JP2967523B2 (ja) | 眼病用製薬組成物 | |
CN108338980A (zh) | 绿原酸在制备防治眼部炎症的药物中的用途 | |
JPH08508975A (ja) | 眼科薬送達ビヒクルとしてのサブミクロン乳剤 | |
WO2001028553A1 (en) | Rivastigmine for the treatment of ocular disorders | |
RU2434633C2 (ru) | Фармацевтические препаративные формы латрункулина | |
Grehn et al. | Thymoxamine: a miotic for intraocular use | |
Jay et al. | Further studies on the effect of retrobulbar epinephrine injection on ocular and optic nerve blood flow | |
US5279836A (en) | Topical use of calcitonin for the preparation of medications in senile idiopathic cataract and a pharmaeutical composition thereof | |
Alani et al. | The ophthalmic rod—a new drug-delivery system II | |
RU2051651C1 (ru) | Основа для глазных капель | |
Yamaguchi et al. | Corticosteroid therapy after anterior radial keratotomy in primates | |
ZALTA et al. | The effect of nitroglycerin ointment on the external ocular structures of rabbits | |
Polak | Drugs used in ocular treatment | |
Kralinger et al. | Acetyl-Salicylsäure–Silikonöl-Suspension bei proliferativer Vitreoretinopathie: Erste Ergebnisse der österreichischen Multicenter-Studie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |